Selected article for: "crucial role and inflammatory process"
Author: Taoufik, Yassine; de Goër de Herve, Marie-Ghislaine; Corgnac, Stéphanie; Durrbach, Antoine; Mami-Chouaib, Fathia
Title: When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
  • Cord-id: lsdxowac
  • Document date: 2021_9_24
    • ID: lsdxowac
    Snippet: Since its emergence at the end of 2019, SARS-CoV-2 has spread worldwide at a very rapid pace. While most infected individuals have an asymptomatic or mild disease, a minority, mainly the elderly, develop a severe disease that may lead to a fatal acute respiratory distress syndrome (ARDS). ARDS results from a highly inflammatory immunopathology process that includes systemic manifestations and massive alveolar damages that impair gas exchange. The present review summarizes our current knowledge i
    Document: Since its emergence at the end of 2019, SARS-CoV-2 has spread worldwide at a very rapid pace. While most infected individuals have an asymptomatic or mild disease, a minority, mainly the elderly, develop a severe disease that may lead to a fatal acute respiratory distress syndrome (ARDS). ARDS results from a highly inflammatory immunopathology process that includes systemic manifestations and massive alveolar damages that impair gas exchange. The present review summarizes our current knowledge in the rapidly evolving field of SARS-CoV-2 immunopathology, emphasizing the role of specific T cell responses. Indeed, accumulating evidence suggest that while T-cell response directed against SARS-CoV-2 likely plays a crucial role in virus clearance, it may also participate in the immunopathology process that leads to ARDS.

    Search related documents:
    Co phrase search for related documents
    • ace enzyme and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace enzyme and acute infection patient: 1
    • ace enzyme and acute lung failure: 1, 2, 3, 4, 5, 6
    • ace enzyme and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace enzyme and acute phase: 1, 2, 3, 4, 5
    • ace enzyme and acute sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace enzyme and acute sars infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace enzyme and acute viral infection: 1, 2, 3
    • ace enzyme and adaptive innate: 1, 2, 3, 4
    • activation platelet aggregation and acute infection: 1, 2
    • activation platelet aggregation and acute lung injury: 1, 2
    • activation platelet aggregation and acute sars: 1, 2, 3, 4, 5
    • activation platelet aggregation and acute sars infection: 1
    • activation platelet aggregation and acute viral infection: 1
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and add benefit: 1
    • acute infection and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and add benefit: 1, 2
    • acute lung failure and adaptive innate: 1